Back
Novo Nordisk A/S Quote, Financials, Valuation and Earnings
Buy
60
NVO
Novo Nordisk A/S
Last Price:
131.88
Seasonality Move:
4.24%
7 Day Trial
ALL ACCESS PASS
$
7
Novo Nordisk A/S Price Quote
$131.88
-0.01 (-0.87%)
(Updated: May 18, 2024 at 5:50 AM ET)
Novo Nordisk A/S Key Stats
Buy
60
Novo Nordisk A/S (NVO)
is a Buy
Day range:
$130.85 - $132.09
52-week range:
$75.56 - $138.28
Dividend yield:
1.04%
P/E ratio:
48.79
P/S ratio:
16.64
P/B ratio:
41.06%
Volume:
2.6M
Avg. volume:
3.8M
1-year change:
57.86%
Market cap:
$587.5B
Revenue:
$33.7B
EPS:
$2.9
How Much Does Novo Nordisk A/S Make?
-
How Much Are Novo Nordisk A/S's Sales Annually?
NVO Revenues are $33.7B -
How Much Profit Does Novo Nordisk A/S's Make A Year?
NVO net income is $12.1B
Is Novo Nordisk A/S Growing As A Company?
-
What Is Novo Nordisk A/S's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.24% -
What Is Novo Nordisk A/S's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0.31%
Novo Nordisk A/S Stock Price Performance
-
Did Novo Nordisk A/S Stock Go Up Last Month?
Novo Nordisk A/S share price went up by 5.91% last month -
Did NVO's Share Price Rise Over The Last Year?
NVO share price rose by 57.86% over the past 1 year
What Is Novo Nordisk A/S 52-Week High & Low?
-
What Is Novo Nordisk A/S’s 52-Week High Share Price?
Novo Nordisk A/S has traded as high as $138.28 over the past 52 weeks -
What Is Novo Nordisk A/S’s 52-Week Low Share Price?
Novo Nordisk A/S has traded as low as $75.56 over the past 52 weeks
Novo Nordisk A/S Price To Free Cash Flow
-
Is Novo Nordisk A/S Stock Overvalued?
Novo Nordisk A/S is trading at a price to free cash flow ratio of 80.68 -
Is Novo Nordisk A/S Stock Undervalued?
Novo Nordisk A/S EV to Free Cash Flow ratio is 80.50 -
What Is Novo Nordisk A/S’s Price Earnings Growth Ratio?
NVO PEG ratio is 0.86 -
Is Novo Nordisk A/S Trading At A Premium To Earnings?
Novo Nordisk A/S EV to EBIT ratio is 35.47
Is It Risky To Buy Novo Nordisk A/S?
-
How Much Debt Does Novo Nordisk A/S Have?
Total long term debt quarterly is $3.9B -
How Much Cash Does Novo Nordisk A/S Have?
Cash and short term investments quarterly total is $1.3B -
What Is Novo Nordisk A/S’s Book Value Per Share?
Book value per share is 3.21
Is Novo Nordisk A/S Cash Flow Positive?
-
What Is NVO Cash Flow From Operations?
Cash flow from operations (TTM) is $13.6B -
What Is Novo Nordisk A/S’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$10B -
What Is Novo Nordisk A/S’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$4.8B
Novo Nordisk A/S Return On Invested Capital
-
Is Management Doing A Good Job?
NVO return on invested capital is 75.11% -
What Is Novo Nordisk A/S Return On Assets?
ROA measures how assets are converting to revenues and is 30.93% -
What Is NVO Return On Equity?
ROE is a measure of profitability and is 95.26%
Novo Nordisk A/S Earnings Date & Stock Price
-
What Is Novo Nordisk A/S's Stock Price Today?
A single share of NVO can be purchased today for 131.89 -
What Is Novo Nordisk A/S’s Stock Symbol?
Novo Nordisk A/S trades on the nyse under the ticker symbol: NVO -
When Is Novo Nordisk A/S’s Next Earnings Date?
The next quarterly earnings date for Novo Nordisk A/S is scheduled on August 7, 2024 -
When Is NVO's next ex-dividend date?
Novo Nordisk A/S's next ex-dividend date is March 22, 2024 -
How To Buy Novo Nordisk A/S Stock?
You can buy Novo Nordisk A/S shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Novo Nordisk A/S Competitors
-
Who Are Novo Nordisk A/S's Competitors?
Below is a list of companies who compete with Novo Nordisk A/S or are related in some way:
Novo Nordisk A/S Dividend Yield
-
What Is NVO Dividend Yield?
Novo Nordisk A/S’s dividend yield currently is 1.04% -
What Is Novo Nordisk A/S’s Payout Ratio?
Novo Nordisk A/S’s payout ratio is 47.16% -
When Did Novo Nordisk A/S Last Pay A Dividend?
The latest dividend pay date is May 18, 2024 -
What Is Novo Nordisk A/S’s Dividend Per Share?
Novo Nordisk A/S pays a dividend of $0.94 per share
Novo Nordisk A/S Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 30.68% | 5.64% |
| Revenue: | 23.68% | 2.97% |
Analyst Recommendations
| Buy Recommendations: | 5 |
|---|---|
| Hold Recommendations: | 1 |
| Sell Recommendations: | 0 |
| Price Target: | 139.36 |
| Upside from Last Price: | 5.66% |